Pharmacotherapy for Liver Cirrhosis and Its Complications (2022) Xingshun Qi

Description

A text focusing on the pharmacotherapy, diagnosis, and assessment of chronic liver disease, specifically liver cirrhosis and its complications. It covers increasing worldwide morbidity, mortality rates, and main causes including alcohol, viral hepatitis B and C, and metabolic dysfunction-associated fatty liver disease (MAFLD).